Internal restructuring
European Union
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

800 jobs
Number of planned job losses
Job loss
Announcement Date
7 June 2010
Employment effect (start)
Foreseen end date


On 7 June, Stada, a German manufacturer and global trader of generics and branded pharmaceutical products, announced details of a new growth program which will result in the loss of 800 jobs across Europe.

According to Stada's press release, this project should reduce the complexity of group structures, make centralized control of group companies more efficient and accelerate continuous cost optimization with a focus on the fields of cost of sales/production locations as well as organizational, reporting and personnel structures. This will also involve the sale or abandonment of production facilities as well as outsourcing individual functional areas to third-party providers.

The program will also result, in the short and mid-term, in significant staff reductions in all Company divisions and regions, which, including outsourcing and sales, involves approx. 800 full-time positions and thus approx. 10% of the current personnel level in the Group; the focus of the staff reductions will be outside of Germany. There is no more information on the planned job cuts.



Eurofound (2010), Stada, Internal restructuring in European Union, factsheet number 70619, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/70619.